Compound ID | 3103
Class: Glycopeptide
Spectrum of activity: | Gram-positive |
Details of activity: | Active against Staphylococcus aureus and Streptococcus haemolyticus; cell wall synthesis inhibitor |
Description: | Natural product from Streptomyces platensis; shows necrotoxic properties on injection sites when administered via subcutaneous or intramuscular route; protects mice from Staphylococcus aureus infection |
Institute where first reported: | Chugai Pharmaceutical Co., Ltd. |
Year first mentioned: | 1975 |
Development status: | Experimental |